NRx Pharmaceuticals to Present at the Sidoti Virtual Small Cap Conference

RADNOR, Pa., Sept. 18, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that Stephen Willard, J.D., Chief Executive Officer and Dr. Jonathan Javitt, Chief Scientist of NRx…

Click here to view original post